Stroke: Novel Molecular Mechanisms and Therapeutic Approaches
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 December 2025 | Viewed by 1975
Special Issue Editor
Special Issue Information
Dear Colleagues,
The special issue "Stroke: Novel Molecular Mechanisms and Therapeutic Approaches" is a collection dedicated to exploring recent advances in the emerging molecular basis and treatment of stroke and neurotrauma.
Our focus concerns the latest updates on the pathophysiology, diagnosis, monitoring, and treatments for cerebrovascular disease. Researchers and clinicians will share their experiences and results in the latest research advances and novel therapeutic approaches. This Special Issue aims to provide the scientific community with an in-depth understanding of the pathogenesis and molecular pathways of cerebrovascular diseases to provide the basis for developing new treatments. The Special Issue will include treatment innovations in cerebrovascular disease and neurotrauma, including drug therapy, nano therapy, gene therapy, stem cell therapy, and the latest technology.
This Special Issue will comprehensively select recent research topics and review articles. We invite submissions on various issues related to novel and emerging molecular mechanisms and therapeutic approaches in stroke. These include exploratory or fundamental scientific studies, preclinical, cross-sectional, and clinical studies, and systematic and narrative/comprehensive reviews. We hope this collection will be a valuable guide for researchers and clinicians.
Dr. Kang-Ho Choi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stroke
- cerebrovascular disease
- mechanisms
- treatment
- diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
